trial

Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia

NCTId NCT04781179
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 68 (estimated)
Sponsored by University Hospital, Montpellier
Primary completion 2023-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
68 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2022-02-22
Primary completion
2023-09
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
CM-IIPsychoeducation

Sponsors

University Hospital, MontpellierLead Sponsor

Sites

1 total
Montpellier, France

Facts & assertions

4 sourced
Enrollment
68
Phase
NA
Primary Completion Date
2023-09
Status
UNKNOWN
relationships
The graph out of here
drug
CM-II
drug
Psychoeducation
drug
lead_sponsor
University Hospital, Montpellier
company
indication
Lethargy
indication
Schizophrenia
indication
Apathy
indication